Thrivent Financial for Lutherans Increases Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Thrivent Financial for Lutherans increased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 37.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 66,599 shares of the financial services provider’s stock after buying an additional 18,123 shares during the period. Thrivent Financial for Lutherans owned about 0.14% of iShares Biotechnology ETF worth $8,838,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in IBB. BNP Paribas Financial Markets increased its position in shares of iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $55,010,000. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $18,476,000. Finally, Generali Investments CEE investicni spolecnost a.s. purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $11,370,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.6 %

Shares of NASDAQ:IBB opened at $133.58 on Friday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The company’s 50 day moving average is $136.23 and its two-hundred day moving average is $139.34. The company has a market cap of $6.31 billion, a PE ratio of 27.83 and a beta of 0.84.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were issued a $0.1212 dividend. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.